업무사례

중재 및 기타 분쟁해결 방안

About

Sidestepping costly choices to find better answers

Finnegan has one of the strongest reputations for litigating IP disputes through trial and appeal. But when circumstances merit its use, we favor alternative dispute resolution (ADR). We often develop a litigation strategy designed to meet goals through ADR instead of trial.

Our ADR capabilities run the gamut from resolution of domestic infringement cases to settlement of multinational infringement disputes, resulting in agreements that set standards to be used as the basis for future patent challenges. Over the past decade, we have participated in a number of important national and international ADR proceedings with the International Chamber of Commerce, the World Intellectual Property Organization, and the American Arbitration Association.

We have national and international experience in a variety of ADR procedures, including mediations before U.S. magistrate judges, under pilot programs of various U.S. district courts, before neutral experts, through various ADR organizations, and in open negotiations between principals and their lawyers. Our attorneys often act as neutral lawyers and have served as special masters and court-appointed advisors for patent cases in U.S. district courts across the country.

Everyone in this practice

업무사례

Represented CSRC in two arbitrations and one litigation relating to exclusive licenses and patent assignments for patents directed to treating Pompe Disease, a rare genetic disorder that is often fatal if untreated. Secured a $180 million settlement from Genzyme.

01-19-0001-6937; 01-20-0000-5081, AAA

Represented a major U.S. pharmaceutical company in two arbitrations concerning a leading biologic. Finnegan’s client won both arbitrations and, in the second, was awarded its attorney fees.

Represented a U.S. pharmaceutical company in an arbitration with a former consultant and inventor. The dispute involved issues relating to inventorship and ownership, as well as the determination of royalties due under various agreements. The matter settled shortly before the hearing on favorable terms.

Member of team that represented AbbVie Biotechnology Ltd. and Abbott GmbH in a WIPO arbitration related to patent licensing.

WIPOA120712, WIPO

Counsel for Cumberland in ANDA litigation and breach of contract arbitration. Successful outcome in bench trial, arbitration, arbitration fee award, and appeal.

16-1155, -1259, Fed. Cir., Judges Moore, Reyna, Taranto
1:12-cv-03846, N.D. Ill., Judge Pallmeyer

Guided Anoto through a successful European arbitration proceeding to enforce a supply agreement for a critical component of Anoto’s products, and then spearheaded a successful effort to enforce the arbitrator’s decision in the United States.

3:16-cv-06209, N.D. Cal., Judge Tigar